Arkolith/Insider Trading/AGL/Form 4/A

Schwaneke Jeffrey A.

Chief Financial Officeragilon health, inc. (AGL) · full profile →Form 4/A · filed Apr 3, 2025
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2025Grant(A)429K—$01.1M
Nov 29, 2023Buy(P)22K$11.22$250K22K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2025Grant(A)673K—$0673K

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001628280-25-016684) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML